Iopamidol, also known as iodopeptidol, iodopentanol, iopamidol, iopamidol, iopamido, iopamisone, is a non-ionic water-soluble contrast agent, which is a drug for imaging diagnosis.
This report contains market size and forecasts of Iopamidol API in global, including the following market information:
Global Iopamidol API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Iopamidol API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Iopamidol API companies in 2021 (%)
The global Iopamidol API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Original Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Iopamidol API include Bracco Imaging, Stellite and Stellite, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Iopamidol API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Iopamidol API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Iopamidol API Market Segment Percentages, by Type, 2021 (%)
Original Drug
Generic Drug
Global Iopamidol API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Iopamidol API Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Iopamidol API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Iopamidol API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Iopamidol API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Iopamidol API revenues share in global market, 2021 (%)
Key companies Iopamidol API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Iopamidol API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bracco Imaging
Stellite
Stellite